null
ChEBI ID: 35315
| Member | Definition | Role |
|---|---|---|
| aclacinomycin | An anthracycline that is aklavinone having an alpha-L-rhodosaminyl residue attached at position 4 via a glycosidic linkage. | aclacinomycin T zwitterion; aclacinomycin T |
| adriamycinol | A member of the class of tetracenequinones that is the major metabolite of the anthracycline doxorubicin, a chemotherapeutic agent effective against a broad range of malignant neoplasms. It is thought to exhibit cardiotoxic properties. | doxorubicinol |
| epirubicin | An anthracycline that is the 4'-epi-isomer of doxorubicin. | 4'-epidoxorubicin |
| idarubicin | idarubicin |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 618 (8.92) | 18.7374 |
| 1990's | 1,852 (26.74) | 18.2507 |
| 2000's | 2,134 (30.81) | 29.6817 |
| 2010's | 1,932 (27.89) | 24.3611 |
| 2020's | 391 (5.64) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 2,311 (30.46%) | 5.53% |
| Reviews | 432 (5.69%) | 6.00% |
| Case Studies | 841 (11.08%) | 4.05% |
| Observational | 31 (0.41%) | 0.25% |
| Other | 3,972 (52.35%) | 84.16% |